Generative AI In Medicine Global Market Report 2024

Description

Generative artificial intelligence (AI) in medicine involves using AI systems to create new data, models, or insights to advance healthcare and medical research. Its goal is to enhance diagnosis, treatment, and overall patient care by leveraging data-driven insights and innovative solutions.

Key components of generative AI in medicine include solutions and services. In this context, solutions refer to the advanced technologies and tools designed to improve healthcare delivery and outcomes. These solutions cover a broad range of applications, such as AI-driven diagnostic tools, virtual nursing assistants, and platforms for medical imaging analysis. Key functions include virtual nursing assistants, robot-assisted AI surgery, administrative process optimization, and medical imaging analysis. Applications span medical imaging, drug discovery, medical diagnosis, patient data analysis, and more. These technologies are utilized by various end-users, including hospitals and clinics, clinical research organizations, healthcare organizations, diagnostic centers, and others.

The generative artificial intelligence (AI) in medicine market research report is one of a series of new reports from The Business Research Company that provides generative artificial intelligence (AI) in medicine market statistics, including generative artificial intelligence (AI) in medicine industry global market size, regional shares, competitors with a generative artificial intelligence (AI) in medicine market share, detailed generative artificial intelligence (AI) in medicine market segments, market trends and opportunities, and any further data you may need to thrive in the generative artificial intelligence (AI) in medicine industry. This generative artificial intelligence (AI) in medicine market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The generative artificial intelligence (AI) in medicine market size has grown exponentially in recent years. It will grow from $0.46 billion in 2023 to $0.66 billion in 2024 at a compound annual growth rate (CAGR) of 43.5%. The growth observed in the historic period can be attributed to increased computational power and advancements in machine learning algorithms, the expansion of precision medicine, a rising demand for drug discovery, greater adoption of AI in diagnostic imaging, and increased investment in AI research and development.

The generative artificial intelligence (AI) in medicine market size is expected to see exponential growth in the next few years. It will grow to $2.81 billion in 2028 at a compound annual growth rate (CAGR) of 43.6%. The anticipated growth during the forecast period is driven by the increasing availability of high-quality medical data, a heightened focus on preventive healthcare, the growing need for efficient clinical trials, rising demand for AI-enhanced patient engagement tools, and the expanding use of AI for drug repurposing. Key trends expected to shape this period include technological advancements, telemedicine, personalized medicine, predictive analytics, and wearable health technology.

The growth of the generative artificial intelligence (AI) in medicine market is expected to be driven by the increase in digital health records. Digital health records, or electronic health records (EHRs), are systematic collections of patient health information stored electronically, which facilitate sharing across healthcare settings and enhance the efficiency and quality of patient care. This surge in digital health records is fueled by improvements in patient care, greater efficiency in healthcare delivery, regulatory support and incentives, technological advancements, and enhanced patient engagement and empowerment. AI in medicine enhances digital health records by automating documentation, organizing data, providing predictive insights, and generating personalized summaries to improve accuracy, accessibility, and overall patient care. For example, in July 2024, the European Commission reported that access to electronic health records increased to 79% in 2024 from 72% in 2023. Thus, the rise in digital health records is significantly driving the growth of the generative AI in medicine market.

Leading companies in this market are concentrating on developing innovative technologies, such as AI solutions for brain health and wellness, to advance cognitive assessment, improve patient care, and enhance mental health management. AI solutions for brain health and wellness are advanced technologies designed to assess, monitor, and improve cognitive function and mental well-being. For instance, in February 2024, DiagnaMed Holdings Corp., a Canada-based company specializing in AI-powered digital therapeutics, launched CERVAI, the first AI solution for human mental health and wellness. This solution utilizes advanced AI to comprehensively evaluate cognitive function and brain wellness. It features cutting-edge algorithms that analyze various data inputs, including cognitive tests and brain imaging, to provide accurate insights into mental health conditions. The tool offers personalized assessments and actionable recommendations, facilitating early detection of cognitive issues and tailored interventions.

In March 2022, Microsoft Corporation, a US-based technology company, acquired Nuance Communications Inc. for an undisclosed amount. This acquisition aims to enhance Microsoft's AI-driven, cloud-based solutions across various industries, improving customer experiences and productivity through advanced conversational AI and ambient intelligence. Nuance Communications Inc., a US-based software technology corporation, focuses on integrating generative AI into the healthcare sector.

Major companies operating in the Generative AI in medicine market are Microsoft Corporation, Intel Corporation, International Business Machines Corporation, NVIDIA Corporation, Philips Healthcare, Veeva Systems Inc., Nuance Communications Inc., Babylon Health Ltd., Tempus Labs Inc., DeepMind Technologies Limited, Owkin Inc., Viz.AI inc., Recursion Pharmaceuticals Inc., Caresyntax Inc., Relay Therapeutics Inc., Exscientia plc, Paige AI inc., BenevolentAI Limited, Atomwise Inc., Healx Ltd., Zebra Medical Vision Ltd., Eyenuk Inc., Syntegra Ltd., Arterys Inc.

North America was the largest region in the generative artificial intelligence (AI) in medicine market in 2023. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the Generative AI in medicine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the Generative AI in medicine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The generative artificial intelligence (AI) in medicine market consists of revenues earned by entities providing services such as drug discovery and development, clinical trials, diagnostics, and virtual health assistants. The market value includes the value of related goods sold by the service provider or included within the service offering. The generative artificial intelligence (AI) in medicine market also includes medical imaging analysis tools, drug discovery platforms, clinical decision support systems, patient data synthesis solutions, administrative automation software, and precision medicine applications. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Generative AI In Medicine Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on generative AI in medicine market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for generative AI in medicine ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The generative AI in medicine market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Component: Solutions; Service
2) By Function: Virtual Nursing Assistants; Robot-Assisted AI Surgery; Administrative Process Optimization; Medical Imaging Analysis
3) By Application: Medical Imaging; Drug Discovery; Medical Diagnosis; Patient Data Analysis; Other Applications
4) By End-User: Hospitals And Clinics; Clinical Research; Healthcare Organizations; Diagnostic Centers; Other End-Users
Companies Mentioned: Microsoft Corporation; Intel Corporation; International Business Machines Corporation; NVIDIA Corporation; Philips Healthcare
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r20618

1. Executive Summary

2. Generative Artificial Intelligence (AI) In Medicine Market Characteristics

3. Generative Artificial Intelligence (AI) In Medicine Market Trends And Strategies

4. Generative Artificial Intelligence (AI) In Medicine Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global Generative Artificial Intelligence (AI) In Medicine Market Size and Growth

5.1. Global Generative Artificial Intelligence (AI) In Medicine Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Generative Artificial Intelligence (AI) In Medicine Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Generative Artificial Intelligence (AI) In Medicine Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Generative Artificial Intelligence (AI) In Medicine Market Segmentation

6.1. Global Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Solutions
Service
6.2. Global Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Function, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Virtual Nursing Assistants
Robot-Assisted AI Surgery
Administrative Process Optimization
Medical Imaging Analysis
6.3. Global Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Medical Imaging
Drug Discovery
Medical Diagnosis
Patient Data Analysis
Other Applications
6.4. Global Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Hospitals And Clinics
Clinical Research
Healthcare Organizations
Diagnostic Centers
Other End-Users

7. Generative Artificial Intelligence (AI) In Medicine Market Regional And Country Analysis

7.1. Global Generative Artificial Intelligence (AI) In Medicine Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Generative Artificial Intelligence (AI) In Medicine Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Generative Artificial Intelligence (AI) In Medicine Market

8.1. Asia-Pacific Generative Artificial Intelligence (AI) In Medicine Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Generative Artificial Intelligence (AI) In Medicine Market

9.1. China Generative Artificial Intelligence (AI) In Medicine Market Overview
9.2. China Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Generative Artificial Intelligence (AI) In Medicine Market

10.1. India Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Generative Artificial Intelligence (AI) In Medicine Market

11.1. Japan Generative Artificial Intelligence (AI) In Medicine Market Overview
11.2. Japan Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Generative Artificial Intelligence (AI) In Medicine Market

12.1. Australia Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Generative Artificial Intelligence (AI) In Medicine Market

13.1. Indonesia Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Generative Artificial Intelligence (AI) In Medicine Market

14.1. South Korea Generative Artificial Intelligence (AI) In Medicine Market Overview
14.2. South Korea Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Generative Artificial Intelligence (AI) In Medicine Market

15.1. Western Europe Generative Artificial Intelligence (AI) In Medicine Market Overview
15.2. Western Europe Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Generative Artificial Intelligence (AI) In Medicine Market

16.1. UK Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Generative Artificial Intelligence (AI) In Medicine Market

17.1. Germany Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Generative Artificial Intelligence (AI) In Medicine Market

18.1. France Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Generative Artificial Intelligence (AI) In Medicine Market

19.1. Italy Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Generative Artificial Intelligence (AI) In Medicine Market

20.1. Spain Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Generative Artificial Intelligence (AI) In Medicine Market

21.1. Eastern Europe Generative Artificial Intelligence (AI) In Medicine Market Overview
21.2. Eastern Europe Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Generative Artificial Intelligence (AI) In Medicine Market

22.1. Russia Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Generative Artificial Intelligence (AI) In Medicine Market

23.1. North America Generative Artificial Intelligence (AI) In Medicine Market Overview
23.2. North America Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Generative Artificial Intelligence (AI) In Medicine Market

24.1. USA Generative Artificial Intelligence (AI) In Medicine Market Overview
24.2. USA Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Generative Artificial Intelligence (AI) In Medicine Market

25.1. Canada Generative Artificial Intelligence (AI) In Medicine Market Overview
25.2. Canada Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Generative Artificial Intelligence (AI) In Medicine Market

26.1. South America Generative Artificial Intelligence (AI) In Medicine Market Overview
26.2. South America Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Generative Artificial Intelligence (AI) In Medicine Market

27.1. Brazil Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Generative Artificial Intelligence (AI) In Medicine Market

28.1. Middle East Generative Artificial Intelligence (AI) In Medicine Market Overview
28.2. Middle East Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Generative Artificial Intelligence (AI) In Medicine Market

29.1. Africa Generative Artificial Intelligence (AI) In Medicine Market Overview
29.2. Africa Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Generative Artificial Intelligence (AI) In Medicine Market Competitive Landscape And Company Profiles

30.1. Generative Artificial Intelligence (AI) In Medicine Market Competitive Landscape
30.2. Generative Artificial Intelligence (AI) In Medicine Market Company Profiles
- 30.2.1. Microsoft Corporation
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. Intel Corporation
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. International Business Machines Corporation
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. NVIDIA Corporation
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. Philips Healthcare
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Generative Artificial Intelligence (AI) In Medicine Market Other Major And Innovative Companies

31.1. Veeva Systems Inc.
31.2. Nuance Communications Inc.
31.3. Babylon Health Ltd.
31.4. Tempus Labs Inc.
31.5. DeepMind Technologies Limited
31.6. Owkin Inc.
31.7. Viz.ai Inc.
31.8. Recursion Pharmaceuticals Inc.
31.9. Caresyntax Inc.
31.10. Relay Therapeutics Inc.
31.11. Exscientia plc
31.12. Paige AI Inc.
31.13. BenevolentAI Limited
31.14. Atomwise Inc.
31.15. Healx Ltd.

32. Global Generative Artificial Intelligence (AI) In Medicine Market Competitive Benchmarking

33. Global Generative Artificial Intelligence (AI) In Medicine Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Generative Artificial Intelligence (AI) In Medicine Market

35. Generative Artificial Intelligence (AI) In Medicine Market Future Outlook and Potential Analysis

35.1 Generative Artificial Intelligence (AI) In Medicine Market In 2028 - Countries Offering Most New Opportunities
35.2 Generative Artificial Intelligence (AI) In Medicine Market In 2028 - Segments Offering Most New Opportunities
35.3 Generative Artificial Intelligence (AI) In Medicine Market In 2028 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer